mutant idh inhibits hnf alpha block hepatocyte differentiation promote biliary cancer
mutations isocitrate dehydrogenase idh1 idh2 among common genetic alterations intrahepatic cholangiocarcinoma ihcc deadly liver cancer- mutant idh proteins ihcc malignancies acquire abnormal enzymatic activity allowing themto convert alpha-ketoglutarate alpha kg hydroxyglutarate 2hg inhibits activity multiple alpha kg-dependent dioxygenases results alterations cell differentiation survival extracellular matrix maturation- however molecular pathways idh mutations lead tumour formation remain unclear show mutant idh blocks liver progenitor cells undergoing hepatocyte differentiation production 2hg suppression hnf alpha master regulator hepatocyte identity quiescence correspondingly genetically engineered mouse models expressing mutant idh adult liver show aberrant response hepatic injury characterized hnf alpha silencing impaired hepatocyte differentiation markedly elevated levels cell proliferation moreover idh kras mutations genetic alterations co-exist subset human ihccs4 cooperate drive expansion liver progenitor cells development premalignant biliary lesions progression metastatic ihcc studies provide functional link idh mutations hepatic cell fate ihcc pathogenesis present novel genetically engineered mouse model idh-driven malignancy
